Allan Camaisa

Allan Camaisa serves as Chairman of the Board of Directors and has been the CEO of Calidi Biotherapeutics since November 2017. Allan was an early investor in Calidi, and determined to bring a cure for difficult-to-treat cancers to market after losing his own father to cancer. As Chairman and CEO, he has successfully led a $20M early-stage Series A round and has been actively involved in recruiting key Board Members and leading MD’s and PhD’s to the Company’s Scientific Advisory Board. Allan’s background includes leading the Calidi Bio team in successful license negotiations with large pharmaceutical firms, and signing a collaboration agreement with the National Institutes of Health.

Previously, Mr. Camaisa was the CEO and Chairman of Parallel6, Inc., a digital mobile/cloud software platform for managing pharmaceutical patient clinical trials that engaged clinical trial participants and powered the enrollment, management, and retention of those participants on behalf of pharmaceutical organizations. Parallel6 sold to PRA Health Sciences in 2017. Their clients included Sanofi, STSI/Genentech, Johnson & Johnson/Janssen, Abbott/Abbvie, PPD, PRA Health, Pfizer, Roche, and the NIH.

In 2005, Mr. Camaisa founded Anakam, Inc., a software security company, focused on healthcare, which safeguarded digital medical records through a platform that delivered government-level multifactor authentication and security. Anakam sold a global license to the Veterans Administration (VA) to secure access to the VA’s primary patient portal called My HealtheVet. Other notable Anakam clients included the Center for Medicare and Medicaid, the Department of Homeland Security and several medical device companies including Boston Scientific and EntraHealth. Anakam was recognized by the Inc.500 as one of the fastest growing companies in the U.S. and was acquired by Equifax in 2010. Prior to Anakam, Mr. Camaisa founded High Technology Solutions (HTS), a software systems integrator that he grew from two people to more than 500 employees and $50 million in revenue. HTS was recognized as an Inc.500 company three years in a row and was sold to Wireless Facilities, Inc. (now Kratos Defense) in 2004.

Before entering business, Mr. Camaisa served eight years as a surface warfare officer in the United States Navy. He currently owns seven U.S. patents and has received numerous awards including the Deloitte FAST 50, the Governor’s Small Business of the Year Award, and the Ernst and Young Regional Entrepreneur of the Year. He also received awards from the San Diego Asian Business Association, Tech America, and the U.S. Small Business Association, which honored him as Small Business Person of the Year. He is a graduate of both the United States Naval Academy and the prestigious Owners Management Program at Harvard Business School. Mr. Camaisa served as a member of the YPO (Young Presidents Organization) San Diego Coastal Chapter. He also served on several volunteer boards including the United Way of San Diego, and Opportunity International (providing micro-enterprise loans to the poor).